Diagnosis and comprehensive therapy for cutaneous neuroendocrine carcinoma of the external auditory canal: a case report and literature review  by Xiu, Qian et al.
ARTICLE IN PRESS+Model
Braz J Otorhinolaryngol. 2016;xxx(xx):xxx--xxx
www.bjorl.org
Brazilian Journal of
OTORHINOLARYNGOLOGY
CASE REPORT
Diagnosis  and comprehensive  therapy  for  cutaneous
neuroendocrine carcinoma  of the  external  auditory
canal: a case  report  and literature  review
Diagnóstico  e  terapia  abrangente  para  carcinoma  neuroendócrino  cutâneo
do canal  auditivo  externo:  relato  de  caso  e  revisão  da  literatura
Qian Xiua, Xue-Ju Wangb, Dong-Dong Zhua,∗, Cui-Da Menga,∗
a Department  of  Otolaryngology,  Head  and  Neck  Surgery,  China-Japan  Union  Hospital  of  Jilin  University,  Changchun,  China
b Department  of  Pathology,  China-Japan  Union  Hospital  of  Jilin  University,  Changchun,  ChinaReceived 21  January  2016;  accepted  8  February  2016
a
s
p
t
r
T
p
C
A
r
m
e
s
h
m
c
p
sIntroduction
Cutaneous  neuroendocrine  carcinoma  (cNEC)  is  a  rare,
aggressive,  malignant  cutaneous  tumor  that  was  ﬁrst
reported  by  Toker1 in  1972.  This  tumor  was  described  as  an
uncommon  skin  lesion  that  showed  a  trabecular  pattern  of
tumor  cell  growth.  The  cNEC  is  also  referred  to  as  Merkel  cell
carcinoma  because  it  is  generally  thought  to  originate  from
Merkel  cells  in  the  basal  layer  of  the  epidermis.  The  most
common  locations  for  cNEC  are  in  the  head  and  neck  in  areas
such  as  the  nasal  cavity,  lymph  node,  and  salivary  glands.2
According  to  large  reviews,  local  recurrence  develops  in
25--30%,  regional  disease  in  52--59%,  and  distant  metastatic
disease  in  34--36%  of  cNEC  cases.3 Local  wide  excision  is
the  recommended  primary  treatment  for  regional  disease,
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This is an open access article under the CC BY license (http://creativecond  postoperative  radiation  and  elective  lymph  node  dis-
ection  may  minimize  locoregional  recurrence.  Herein,  we
resent  a  single  case  of  cNEC  located  at  the  external  audi-
ory  canal;  only  4  cases  of  this  rare  tumor  site  have  been
eported  worldwide  according  to  the  best  of  our  knowledge.
his  case  was  successfully  controlled  with  local  excision  and
ostoperative  radiation  therapy.
ase report
 26-year-old  male  presented  with  a  one-year  history  of
ight  external  auditory  canal  itching,  hearing  loss,  inter-
ittent  pain  and  1  month  of  watery  secretion.  A  clinical
xamination  revealed  a  1.04  cm  in  diameter,  pink,  ovary-
haped  nodule  with  a  smooth  surface  that  was  noted  in
is  right  external  auditory  canal  covering  the  tympanic
embrane  (Fig.  1).  Pure-tone  audiometry  revealed  pure
onductive  loss  with  an  air  conduction  loss  of  30  dB.  A  com-
uted  tomography  (CT)  scan  revealed  a  well-circumscribed
trip  of  solid  mass  in  the  right  external  auditory  canal
ithout  bony  erosion  and  a  medium-density  area  in  the
ympanic  antrum  (Fig.  2). When  the  mass  was  excised  via
ndoscopic  surgery,  some  pink  ﬂuid  was  exuded,  although
n  integrated  tympanic  membrane  and  normal  canal  wall
ciação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial.
mmons.org/licenses/by/4.0/).
BJORL-350; No. of Pages 3
ARTICLE IN PRESS+Model
2  Xiu  Q  et  al.
Figure  1  Endoscope  test  showing  a  pink,  ovary-shaped  neo-
plasm with  a  smooth  surface.  The  tympanic  membrane  was
covered  without  adhering  to  the  adjacent  structure.
Figure  2  Axial  CT  scan  before  surgery  showing  a  well-
circumscribed  strip  of  solid  mass  in  the  right  external  auditory
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Figure  3  Vesicular  nuclei,  eosinophilic  cytoplasm  and
high-density  fragments  could  be  seen  in  some  cells
(hematoxylin--eosin  stain,  magniﬁcation  200×).
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manal without  bony  erosion  and  a  medium-density  area  in  the
ympanic  antrum.
ere  observed.  Histopathologic  ﬁndings  showed  nest,  cord,
land  and  trabecular  proliferations  of  orbicular-ovate  cells
nder  the  squamous  epithelial  layers;  some  irregular  cells
ocated  around  the  nest  were  found  to  have  vesicular
uclei,  eosinophilic  cytoplasm  and  mitotic  morphologies
Fig.  3).  Immunohistochemistry  revealed  strongly  positive
taining  for  cytokeratin  (CK)  and  neuron-speciﬁc  enolase
NSE)  (Fig.  4)  and  moderately  positive  staining  for  vimentin,
howing  a  pattern  consistent  with  neuroendocrine  tumors.
iscussion
he  cNEC  is  also  called  Merkel  carcinoma  because  the  tumor
ell  is  derived  from  epidermal  Merkel  cells.  The  primary
ocus  of  cNEC  on  the  external  ear  is  very  rare.  To  the  best  of
ur  knowledge,  only  24  cases  of  external  ear  cNEC  have  been
eported,  and  only  4  cases  were  found  to  originate  from  the
4--6xternal  auditory  canal.
In  our  patient,  the  symptoms  included  itching,  inter-
ittent  pain,  a  watery  secretion  from  the  right  external
uditory  canal,  and  hearing  loss  due  to  the  neuroendocrine
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migure  4  Immunohistochemistry  for  neuron-speciﬁc  enolase
NSE) (magniﬁcation  100×).
ature  of  cNEC,  whereas  the  cases  of  cNEC  reported  by
ang7 and  Li6 were  described  as  a painless  neoplasm  in
he  external  auditory  canal  with  hearing  loss.  An  orbicular-
vate,  pink,  ﬁrm  neoplasm  with  a  smooth  surface  is  the
haracteristic  morphology  of  cNEC  reported  in  multiple
tudies,  which  is  in  agreement  with  our  case.  The  clini-
al  tests  (particularly  CT  results)  reported  by  other  groups
ave  shown  conductive  hearing  loss  and  a  regularly  shaped
igh-density  area  in  the  external  auditory  canal,  which  is  in
greement  with  our  case  study.
Diagnosis  is  usually  delayed  because  the  clinical  char-
cteristics  of  this  disease  mimic  more  common  otologic
onditions,  such  as  adenoid  cystic  carcinoma.8 Malignant
umors  should  be  considered  if  anti-inﬂammatory  therapies
rovide  no  relief.  Biopsies  should  be  performed  especially
hen  the  neoplasm  has  an  orbicular-ovate,  pink,  ﬁrm
ppearance  with  a  smooth  surface  that  bleeds  after  minimal
ontact.  The  diagnosis  rate  may  be  improved  if  the  afore-
entioned  clinical  characteristics  receive  more  attention.
The  diagnosis  and  staging  of  cNEC  primarily  rely  on  patho-
ogical  examination.  Tissue  analysis  may  reveal  a  trabecular
istribution  of  moderately  differentiated  cells,  showing
lustered  proliferation  in  the  propial  or  dermal  layer,  pleo-
orphic  nuclei  and  inconspicuous  nucleoli.  Furthermore,
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frequent  mitoses  can  be  seen  in  hematoxylin  and  eosin-
stained  sections.  Pyknotic  nuclei,  suggestive  of  apoptosis,
may  also  be  found  in  the  scattered  cell  fragments.  In  our
case,  immunohistochemistry  revealed  that  the  tumor  cells
expressed  cytokeratin,  NSE,  and  vimentin.
A  wide  local  excision  with  a  clear  margin  is  recommended
for  the  treatment  of  cNEC,  with  adjunct  chemotherapy
and  radiation  therapy.  For  those  patients  who  cannot  tol-
erate  wide  surgical  excision,  radical  radiotherapy  may  be
used  solely  as  an  effective  curative  approach  against  cNEC
according  to  Harrington.9 Adjunct  radiotherapy  for  primary
tumors  and  regional  lymph  nodes  has  been  shown  to  result
in  better  local  regional  control  and  disease-free  survival.10
Chemotherapeutics  are  used  in  cases  of  locally  advanced  dis-
ease  or  for  tumors  that  cannot  be  completely  resected,  as  a
palliative  measure  or  in  cases  of  recurrence.  However,  the
use  of  adjuvant  chemotherapy  is  associated  with  decreased
survival  compared  to  not  receiving  chemotherapy.11 The
primary  tumor  in  our  case  study  was  classiﬁed  at  a  low  dis-
ease  stage,  such  that  local  excision  was  applied  without  the
consideration  of  chemotherapy.  However,  the  diagnosis  of
cNEC  was  uncertain  until  a  post-surgical  biopsy  was  per-
formed.  Adjunct  radiotherapy  was  used  due  to  the  concern
that  the  resection  margins  were  not  safe  enough.  In  this
case,  the  follow-up  lasted  for  12  months,  with  no  recru-
descence  or  metastasis  observed.  From  our  perspective,
a  comprehensive  therapy  that  includes  local  excision  with
functional  structure  protection  and  radiotherapy  is  a  novel
and  effective  approach  to  treating  cNEC,  which  may  avoid
the  dysfunction  of  important  anatomic  structures  after  wide
excision.
Conclusion
Cutaneous  neuroendocrine  carcinoma  remains  an  aggressive
tumor  with  a  poor  prognosis.  Preoperative  diagnosis  and
accurate  staging  are  important  in  ensuring  adequate  treat-
ment.  Because  of  the  rarity  of  this  disease,  a  consensus  on
the  diagnosis  and  treatment  of  cNEC  in  the  external  auditory
canal  has  not  been  reached.  We  illustrate  that  cNEC  should
be  considered  in  the  differential  diagnosis  when  a  round
and  ﬁrm  tumor  with  a  smooth  surface  is  seen  in  the  exter-
nal  auditory  canal  with  no  or  minor  symptoms.  Pathology  is
1 PRESS
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he  most  conﬁrmative  diagnosis.  Tumor  resection  with  adju-
ant  radiotherapy  is  recommended  for  the  consideration  and
rotection  of  important  structures.
onﬂicts of interest
he  authors  declare  no  conﬂicts  of  interest.
eferences
1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol.
1972;105:107--10.
2. Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N,
Schwartz AM, Henson DE. Merkel cell carcinoma demograph-
ics, morphology, and survival based on 3870 cases: a population
based study. J Cutan Pathol. 2010;37:20--7.
3. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI,
Beenken SW.  Multimodality treatment of Merkel cell carcinoma:
case series and literature review of 1024 cases. Ann Surg Oncol.
2001;8:204--8.
4. Manipoud P, Mom T, Kemeny JL, Fouilloux G, Lafaye M. Cuta-
neous neuroendocrine carcinoma of the external ear canal. Ann
Otolaryngol Chir Cervicofac. 1994;111:111--4.
5. Litofsky NS, Smith TW, Megerian CA. Merkel cell carcinoma of
the external auditory canal invading the intracranial compart-
ment. Am J Otolaryngol. 1998;19:330--4.
6. Li YK, Chi FL, Wang SY, Wang WQ, Yang JM, Huang YB. Cuta-
neous neuroendocrine carcinoma of the external auditory canal:
a case report and review of the literature. Case Rep Otolaryngol.
2012;2012:941065.
7. Wang LE, Zhang DX, Li YJ, Wang W.  Neuroendocrine carci-
noma in the auditory canal and middle ear. Chin Med J (Engl).
2012;125:3357--8.
8. Carvalho CP, Barcellos AN, Teixeira DC, Sales Jde O, Silva Neto
R. Adenoid cystic carcinoma of the external auditory canal. Braz
J Otorhinolaryngol. 2008;74:794--6.
9. Harrington C, Kwan W.  Outcomes of Merkel cell carcinoma
treated with radiotherapy without radical surgical excision. Ann
Surg Oncol. 2014;21:3401--5.
0. Agelli M, Clegg LX, Becker JC, Rollison DE. The etiology and
epidemiology of Merkel cell carcinoma. Curr Probl Cancer.1. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG.
Merkel cell carcinoma: prognosis and treatment of patients from
a single institution. J Clin Oncol. 2005;23:2300--9.
